Chapter 359 Hans Biopharmaceuticals



Chapter 359 Hans Biopharmaceuticals

In the Hardy Group, everyone who works with Hardy receives management shares, can share in the company's profits, and grow with the company.

In the California Consortium, Hardy led the consortium companies to invest in Europe and Japan, and it can be said that he helped them make huge profits. On the other hand, when Hardy gets into trouble, how can these companies that have profited from him not support him?

The cooperation with the seven major conglomerates has been a win-win cooperation model from the beginning. A large number of companies have been set up in the Cayman Islands to carry out cross-holdings so that everyone can share the profits.

Businessmen are a group of people who pursue profit and are very selfish, but the more such people are, the more they value those who are honest, trustworthy, affectionate and righteous.

During this period, Hardy left an excellent reputation among these conglomerates.

People who are not in the business circle may not understand how important word of mouth is in the business circle. When you ask others to borrow money, they will think twice, or even directly refuse because of your previous reputation. But if Hardy wants to borrow money now, there will definitely be a lot of people willing to lend it to him.

Good reputation lays a good foundation for future cooperation.

There is also the cooperation with politicians. Hadi played a great role in pushing Johnson to be re-elected, but Hadi never showed any arrogance and never made excessive demands that made Johnson feel difficult.

The cooperation with Major General Williams started from asking Williams for help, then changed to helping Williams become deputy director, promoted to major general, and now pushed him to become director of the Logistics Bureau. In fact, the identities of the two have changed.

It can be said that Williams is now a politician supported by Hardy, but Hardy is still polite to Williams. They continue to exchange interests as needed. Their relationship is completely that of collaborators and friends. He does not regard himself as a superior or benefactor.

Now Williams has been promoted to Director of Logistics and will be promoted to Lieutenant General in the future, managing all logistical supplies of the US military. I believe Williams' network will become wider and wider. Given the current relationship between the two, Williams' network is equivalent to Hardy's network.

It will definitely be of great help to him in the future.

"Williams, do you know anyone at Pacific Command?" Hardy asked.

"What about MacArthur? I have a good relationship with the Chief of Staff of the Pacific Command, George Rufus Sutherland. We have studied together before. Sutherland is also in charge of military logistics. The Logistics Department often contacts him. What's wrong?" Williams asked.

"I'm going to arrange an interview with the Global Times with the Pacific Command to report on their achievements in the East. It would be easier to do the job if we have someone we know," said Hardy.

Williams smiled and said, "That's a good thing. I'll send a telegram to Sutherland and ask him to receive the Global Times people."

"But your newspaper is reporting on the Pacific Command, and I guess MacArthur will be even more arrogant." Williams' tone was obviously disdainful when he mentioned MacArthur's name.

"Why, do you hate McArthur?" Hardy said with a smile.

"No one likes that guy, I mean everyone in the military, he's arrogant and always loves Xiu'er, he shouldn't be a soldier, he should be an actor."

"Not to mention the Pentagon, he also doesn't have a good relationship with his subordinates. Sutherland once complained to me that MacArthur never listened to other people's opinions, always took the benefits for himself, and even didn't trust his subordinates. Each of his division commanders had complained about MacArthur, saying that it was very uncomfortable to work with him." Williams said.

After chatting with Williams for a long time, both of them were a little drunk in the end, but they drank very happily. In the end, Hardy's bodyguard took him to the hotel.

the next day,

Hardy returned to Los Angeles.

......

Hardy originally planned to return to Japan after Christmas and New Year and arrange company affairs, but was delayed by Williams's matter.

Next, Hardy's supermarket chain and shipping company will have to cooperate with the military logistics department, and these matters also require Hardy's approval.

So Hardy decided not to go back yet.

In fact, things are already on the right track in Japan, with a team in charge of management, so it doesn't matter if Hardy doesn't go.

Hardy took advantage of this time to arrange the things he had planned before, and he called Andy.

"Andy, find a listed pharmaceutical research company that has certain research capabilities but doesn't need to be too big. It's best if it has a moderate price. Then register a new company in the Cayman Islands and acquire it secretly," said Hardy.

"What are you going to do?" Andy asked.

Hardy approached Andy and told him his plan. Andy's eyes widened in surprise. He didn't expect that his boss had such a big plan.

"Okay, I'll go find it right away."

A few days later,

Andy put the information of a medical research company in front of Hardy, "Hans Biopharmaceuticals USA".

"I checked a lot of pharmaceutical companies and finally locked on this research company. I asked Henry to help investigate this company. It contains the most realistic situation reports. I feel he is a good fit." Andy said.

Hardy read the report carefully.

Hans Biopharmaceuticals was founded 10 years ago and is headquartered in New Jersey. Its owner, Dr. Claire Hans, graduated from the Massachusetts Institute of Technology with a degree in pharmacy and pharmaceutical sciences.

Hans Biopharmaceuticals is a scientific enterprise. When Dr. Hans was in school, he developed an antipyretic drug that was widely recognized and won many awards. Dr. Hans then founded this research-based pharmaceutical company.

After the antipyretic drug was perfected, it was licensed to pharmaceutical manufacturers for production and achieved considerable success. Hans Biopharmaceuticals was also very successful at the time and made a lot of money. Dr. Hans became very ambitious and began to recruit a large number of researchers, purchase instruments, and carry out research on multiple projects.

At its largest scale, this pharmaceutical company had eight PhDs in medicine, medical technology, bioengineering, chemistry, etc. and more than 100 researchers.

Not only do we study drugs, we also study medical devices.

But in the days that followed, Dr. Hans' luck seemed to have run out. He spent a lot of money but failed to develop a valuable new drug. Although he developed several instruments, the market response was mediocre and they eventually came to nothing.

Fortunately, the profits from the antipyretic drugs have allowed this pharmaceutical company to survive. A few years ago, researchers developed streptomycin, a drug that can treat tuberculosis. It should be noted that tuberculosis was previously an incurable disease and an infectious disease with a very high global incidence rate.

Hans Pharmaceuticals had previously researched drugs to treat tuberculosis, but unfortunately they were unsuccessful. After the emergence of streptomycin, Hans saw hope. Streptomycin is a broad-spectrum antibiotic that is effective against tuberculosis, but it is not a specific drug. Dr. Hans plans to develop a better specific drug for tuberculosis based on streptomycin.

However, after investing a lot of money and manpower, there was no effect for several years. In order to raise money, Dr. Hans came up with an idea and hired someone to take Hans Biopharmaceuticals public. In the beginning, he did raise some money and alleviated the company's financial difficulties.

But just last year, bad things happened one after another. First, a new antipyretic drug was launched on the market. The antipyretic drug originally researched by Hans was soon abandoned because it had certain side effects. Without production, there was no profit sharing, and the most important funding chain for Hans Biopharma was broken.

Then a large number of researchers resigned. Later, Hans discovered that better research institutions were poaching their people. Hans Biopharma had not achieved any results in recent years, and its funding chain was broken. It was difficult to pay salaries, let alone bonuses.

As for those PhDs, they came here mainly for the profits from researching and developing drugs, but now that they have gained nothing, they have no intention of staying.

Today, Hans Biopharmaceuticals has only a research institute and a building, with only a dozen researchers and Hans himself as the only leader.

Hans is now operating in debt. In order to maintain his business, he has mortgaged his company, just like making a last-ditch effort to develop a cure for tuberculosis.

If he succeeds, he can return to the top of the world. If he fails, all his efforts over the years will be wasted, and he may even be burdened with a huge debt.

As for the stock of Hans Biopharmaceuticals, because its antipyretic drugs lost the market and there were no research results for many years, investors had already lost confidence in it. The stock price kept falling and is now only a few cents. It can be said to be the junk stock among the junk stocks in the market.

Hardy felt that Hans Biopharmaceuticals met his requirements very well.

"That's it, Andy. Follow the plan. Ask someone to contact Hans and ask him if he wants to sell it. Ask Henry to cooperate. Remember, this company cannot have anything to do with the Hardy Group." Hardy ordered.

"Of course I understand." Andy nodded with a smile.

......

Hans sat in the pub with a glass of wine in front of him, looking tired and decadent. His research still hadn't made any progress, and he had run out of money, owing his employees more than two months' salary.

The company has been mortgaged, and he has used all the means he could, including the equipment in the laboratory.

He had a quarrel with his wife a few days ago. He couldn't afford the household expenses, even the water and electricity bills. He also has three children, who might have to drop out of school if they have no money. He and his wife discussed selling their current house and using the money to support themselves for a while.

The wife exploded and had a big fight with Hans.

Hans was a little afraid to go to the company. He couldn't face the employees who were asking for their wages. He didn't dare go home for fear of seeing the disappointed looks on his wife and children's faces.

The experiments have also been stopped because he has no money to buy materials.

He was now in complete despair.

I have no idea what to do.

Maybe the final outcome will be to declare bankruptcy, then lose your career, your wife will leave you with the children, and you will become a homeless person, living in a shelter or picking food from garbage cans.

Hans picked up the wine glass and drank it down fiercely. The spicy wine made him feel refreshed. He wanted to get drunk. When he was drunk, he wouldn't have to think so much and he would be able to forget everything.

At this moment,

A middle-aged man in his forties sat down next to Hans. Hans looked up and the middle-aged man nodded and smiled at Hans. "Hello, Dr. Hans. Are you interested in chatting?"

"What?"

Hans asked hesitantly.

"Let's talk about Hans Biopharmaceuticals, whether you are willing to save him, and whether you are willing to save yourself and your family." The middle-aged man said with a smile.


Recommendation